Abstract
The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1099-1101 |
| Number of pages | 3 |
| Journal | Neurology |
| Volume | 63 |
| Issue number | 6 |
| DOIs | |
| State | Published - Sep 29 2004 |
ASJC Scopus subject areas
- Clinical Neurology
Fingerprint Dive into the research topics of 'Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination'. Together they form a unique fingerprint.
Cite this
Lipton, R. B., Bigal, M. E., Kolodner, K. B., Gorelick, P. B., Wilks, K., Schoebelock, M., & Davidai, G. (2004). Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination. Neurology, 63(6), 1099-1101. https://doi.org/10.1212/01.WNL.0000138494.66691.07